Shots:

• Merck KGaA & GenScript enter into a collaboration agreement to accelerate the industrialization and commercialization of cell and gene therapy in China. Merck to provide products- services & staff training from lab development to large-scale GMP manufacturing to GenScript
• The focus of the collaboration is to develop a global platform for plasmid and virus manufacturing with the establishment of cGMP manufacturing facilities in China
• Additionally- the companies plan to develop a unit focusing on commercialization and manufacturing of these gene therapy products in China

Ref: Merck KGaA | Image: Merck KGaA